BPR-001

N/A

Report date: 2025/01/08 17:58:32
NME

Base Information

Drug NameBPR-001
Drug Alias NameBPR-001BPR001
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of Action78 kDa glucose-regulated protein modulators
Targets78 kDa glucose-regulated protein
Therapy Area/IndicationsGastrointestinal Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBiPER Therapeutics SAS
China Registration ClassN/A

Develop Information

Active CompaniesBiPER Therapeutics SAS
Inactive CompaniesN/A
Active IndicationsGastrointestinal Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A